Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it is partnering with Pearl Health, a technology company centered on physician enablement in value-based care, to provide personalized support to Medicare patients with dementia.

The collaboration aims to benefit dementia patients and their families through the CMS GUIDE (Guiding an Improved Dementia Experience) program.

Launched in July, the CMS GUIDE program provides online visits with Synapticure neurologists and almost 80 hours of respite care services from skilled providers to relieve caregivers. 

Under the partnership, Pearl Health primary care providers across the country will be able to refer Medicare patients to Synapticure as a part of a proactive, value-based approach strategy.

"Synapticure's partnership with Pearl Health through the GUIDE program democratizes access to high-quality dementia care, including specialized neurologists, behavioral health, and comprehensive caregiver support within a week of consultation," Sandra Abrevaya, caregiver and CEO of Synapticare, said in a statement. "This approach ensures patients receive top-quality care from home."

Dr. Cameron Berg, executive vice president of clinical strategy at Pearl Health, explained that the partnership with Synapticure further supports the company's primary care providers in delivering the right care at the right time. 

"The organizations share a commitment to improving quality of life as well as the highest standards of clinical, technical, and operational aptitude," said Berg. 

THE LARGER TREND

Chicago-based Synapticure launched in 2022 with $6 million in seed funding in a round led by Google Ventures (GV). 

In April, Synapticure partnered with the ALS Association to offer Synapticure’s telehealth platform as a supplement to in-person care at ALS Certified Treatment Centers of Excellence and Recognized Treatment Centers.

In 2023, Pearl Health partnered with Walgreens to expand value-based care options in collaboration with primary care providers. In addition, Pearl raised $55 million in Series B funding and anticipated receiving a $20 million line of credit outside of the equity raise.

Andreessen Horowitz and Viking Global Investors led the 2023 round just two years after the company secured $18 million in Series A funding. 

Pearl has announced numerous partnerships this year, including a collaboration with WellCare, the Medicare brand of Centene, to improve value-based care alongside primary care physicians. 

It also announced a strategic partnership with PraxisCare and Adaugeo Healthcare Solutions to provide access to value-based care services for patients across multiple Medicare Accountable Care Organizations (ACOs), and MDX Hawai'i, a large physician network in Hawaii.